Why people use Thymosin Alpha-1 for cancer support
On chemo and immune system is wrecked. Thymosin Alpha-1? The honest answer: yes, there is real clinical evidence here, not just gym-bro consensus. Approved as Zadaxin for chemotherapy support in 35+ countries.
This page covers what's known, what's not, and what the editorial take is for normal humans considering Thymosin Alpha-1 for cancer support.
What the evidence says
Evidence tier: Strong clinical. Multiple human studies support the dosing protocol; not yet FDA-labeled for this exact indication but close.
- Approved as Zadaxin for chemotherapy support in 35+ countries.
- Multiple oncology RCTs show reduced infection rates and faster immune recovery in chemo patients.
- Oncology coordination essential - this is not a substitute for cancer treatment.
Protocol notes
1.6mg subQ twice weekly during and after chemotherapy. Oncologist or integrative oncologist supervision.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full Thymosin Alpha-1 directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch